Eosinophil innate immune memory after bacterial skin infection promotes allergic lung inflammation
Sci Immunol. 2025 Apr 4;10(106):eadp6231. doi: 10.1126/sciimmunol.adp6231. Epub 2025 Apr 4.
PMID:
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody
J Exp Med. 2025 Jun 2;222(6):e20241930. doi: 10.1084/jem.20241930. Epub 2025 Apr 3.
PMID:
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models
Front Immunol. 2025 Mar 17;16:1524477. doi: 10.3389/fimmu.2025.1524477. eCollection 2025.
PMID:
Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibody
bioRxiv [Preprint]. 2025 Mar 10:2025.03.07.642041. doi: 10.1101/2025.03.07.642041.
PMID:
An aging bone marrow exacerbates lung fibrosis by fueling profibrotic macrophage persistence
Sci Immunol. 2025 Mar 28;10(105):eadk5041. doi: 10.1126/sciimmunol.adk5041. Epub 2025 Mar 28.
PMID:
Highly pathogenic avian influenza H5N1: history, current situation, and outlook
J Virol. 2025 Apr 15;99(4):e0220924. doi: 10.1128/jvi.02209-24. Epub 2025 Mar 27.
PMID:
Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
Cell Rep Med. 2025 Apr 15;6(4):102035. doi: 10.1016/j.xcrm.2025.102035. Epub 2025 Mar 21.
PMID:
The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis
EClinicalMedicine. 2025 Feb 22;81:103115. doi: 10.1016/j.eclinm.2025.103115. eCollection 2025 Mar.
PMID:
Next-generation seasonal influenza virus vaccines need a neuraminidase component
Vaccine. 2025 Apr 30;54:126994. doi: 10.1016/j.vaccine.2025.126994. Epub 2025 Mar 9.
PMID:
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies
mBio. 2025 Apr 9;16(4):e0360724. doi: 10.1128/mbio.03607-24. Epub 2025 Mar 5.
PMID: